Related Experiment Video
Updated: Sep 8, 2025
07:25
Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
Published on: October 13, 2023
3.0K
Ciliopathy: Sjögren-Larsson Syndrome
Stephen H Tsang1, Alicia R P Aycinena2, Tarun Sharma3
1Department of Ophthalmology, Columbia University, New York, NY, USA. sht2@cumc.columbia.edu.
Advances in Experimental Medicine and Biology
|July 30, 2025
Summary
Sjögren-Larsson syndrome results from mutations in the ALDH3A2 gene, impacting fatty aldehyde dehydrogenase (FALDH) function. This impairment in fatty oxidation and metabolite clearance is linked to disease development.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Sjögren-Larsson syndrome is a rare genetic disorder.
- It is characterized by specific clinical manifestations.
- The underlying molecular defect involves the ALDH3A2 gene.
Purpose of the Study:
- To elucidate the role of the ALDH3A2 gene product, fatty aldehyde dehydrogenase (FALDH).
- To understand the contribution of FALDH dysfunction to Sjögren-Larsson syndrome pathogenesis.
- To explore the biochemical consequences of ALDH3A2 mutations.
Main Methods:
- Analysis of the ALDH3A2 gene and its encoded protein, FALDH.
- Investigation of FALDH's function in fatty acid oxidation pathways.
- Examination of cellular and molecular mechanisms related to metabolite clearance.
Main Results:
- Mutations in the ALDH3A2 gene lead to a deficient fatty aldehyde dehydrogenase (FALDH).
- FALDH is identified as a membrane-bound protein crucial for fatty oxidation.
- Structural abnormalities and impaired metabolite clearance are associated with the disease.
Conclusions:
- The ALDH3A2 gene mutation is the causative factor in Sjögren-Larsson syndrome.
- Dysfunctional FALDH disrupts normal fatty oxidation and metabolite processing.
- These disruptions are key contributors to the syndrome's pathogenesis.
More Related Videos
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
81
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
81
01:24Nephrotic Syndrome I : Introduction
25
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
25
01:26Nephrotic Syndrome II : Assessment and Medical Management
21
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
21
01:22Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
01:25Endocarditis II: Clinical Features of Infective Endocarditis
25
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
25
01:23Cystic Fibrosis: Pathogenesis
358
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
358